跳到主要內容

Avalo Therapeutics, Inc.

AVTX
交易所
Nasdaq
產業
Pharmaceutical Preparations
SEC CIK
0001534120

近 90 天,Avalo Therapeutics, Inc. 內部人申報 0 筆公開市場買進、5 筆賣出;2026 年第 2 季末有 126 家機構在 13F 申報持有,市值合計 $13.1 億;沒有大師持有。

持有 AVTX 5% 以上的大股東

最新一份 Schedule 13D 或 13G 申報持有 Avalo Therapeutics, Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。

持有 AVTX 5% 以上的大股東
持有人最新表單持股變化首次申報最新申報原文
Commodore Capital LP13G9.90%股數 572.1 萬新申報2026/6/181 份2026/6/18SEC
TCG Crossover GP II, LLC13G7.90%股數 301.7 萬新申報2026/5/121 份2026/5/12SEC
Farallon Capital Management, L.L.C.13G7.40%股數 397.4 萬新申報2026/11/131 份2026/11/13SEC
Deep Track Capital, LP13G/A6.87%股數 361.0 萬+1.06 個百分點原本 5.81%2024/4/54 份2026/8/14SEC
BlackRock, Inc.13G6.50%股數 341.6 萬新申報2026/7/271 份2026/7/27SEC
Ra Capital Management, L.P.13G/A6.30%股數 348.3 萬−3.60 個百分點原本 9.90%2024/8/236 份2026/8/14SEC
Caligan Partners LP13G/A5.90%股數 316.4 萬−1.30 個百分點原本 7.20%2025/11/144 份2026/8/14SEC
Affinity Asset Advisors, LLC13G/A5.50%股數 290.0 萬0.00 個百分點原本 5.50%2024/12/315 份2026/8/13SEC
Biotechnology Value Fund L P13G/A5.30%股數 280.2 萬−4.69 個百分點原本 9.99%2024/8/236 份2026/8/14SEC
Trails Edge Capital Partners, LP13G5.20%股數 280.4 萬新申報2026/10/291 份2026/10/29SEC
Point72 Asset Management, L.P.13G5.20%股數 271.1 萬+1.70 個百分點原本 3.50%2021/9/218 份2026/5/26SEC

持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。

13D 與 13G 申報

Avalo Therapeutics, Inc. 的 103 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。

AVTX 的 Schedule 13D、13G 申報
申報時間(美東)申報人表單持股變化事件日原文
2026/11/1308:48 ETFarallon Capital Management, L.L.C.等 16 位13G7.40%股數 397.4 萬新申報2026/9/30SEC
2026/11/1006:36 ETState Street Corp13G4.80%股數 256.3 萬−0.70 個百分點原本 5.50%低於 5%2026/9/30SEC
2026/11/609:45 ETFMR LLC等 2 位13G/A0.90%股數 47.4 萬−8.90 個百分點原本 9.80%低於 5%2026/10/30SEC
2026/11/513:10 ETFMR LLC等 2 位13G/A9.80%股數 525.0 萬−1.00 個百分點原本 10.80%2026/9/30SEC
2026/10/2916:15 ETTrails Edge Capital Partners, LP等 3 位13G5.20%股數 280.4 萬新申報2026/10/22SEC
2026/8/1416:40 ETNantahala Capital Management, LLC等 3 位13G/A3.54%股數 186.2 萬−5.85 個百分點原本 9.39%低於 5%2026/6/30SEC
2026/8/1416:40 ETCaligan Partners LP等 2 位13G/A5.90%股數 316.4 萬−1.30 個百分點原本 7.20%2026/6/30SEC
2026/8/1416:38 ETRa Capital Management, L.P.等 4 位13G/A6.30%股數 348.3 萬−3.60 個百分點原本 9.90%2026/6/30SEC
2026/8/1416:01 ETBiotechnology Value Fund L P等 10 位13G/A5.30%股數 280.2 萬−4.69 個百分點原本 9.99%2026/6/30SEC
2026/8/1410:39 ETT. Rowe Price Investment Management, Inc.13G/A0.00%股數 3,670−9.50 個百分點原本 9.50%低於 5%2026/6/30SEC
2026/8/1409:00 ETAvoro Capital Advisors LLC等 2 位13G/A4.44%股數 233.3 萬−1.31 個百分點原本 5.75%低於 5%2026/6/30SEC
2026/8/1408:24 ETDeep Track Capital, LP等 3 位13G/A6.87%股數 361.0 萬+1.06 個百分點原本 5.81%2026/6/30SEC
2026/8/1316:06 ETAffinity Asset Advisors, LLC等 2 位13G/A5.50%股數 290.0 萬0.00 個百分點原本 5.50%2026/6/30SEC
2026/8/711:04 ETFMR LLC等 2 位13G/A10.80%股數 573.8 萬+1.10 個百分點原本 9.70%2026/7/31SEC
2026/8/708:44 ETState Street Corp13G5.50%股數 288.9 萬新申報2026/6/30SEC
2026/8/610:14 ETFMR LLC等 2 位13G/A9.70%股數 510.0 萬+3.60 個百分點原本 6.10%2026/6/30SEC
2026/7/2716:25 ETBlackRock, Inc.13G6.50%股數 341.6 萬新申報2026/6/30SEC
2026/7/617:29 ETMillennium Management LLC等 3 位13G/A0.00%股數 9,857−5.00 個百分點原本 5.00%低於 5%2026/6/30SEC
2026/6/1816:29 ETCommodore Capital LP等 4 位13G9.90%股數 572.1 萬新申報2026/6/11SEC
2026/6/510:13 ETFMR LLC等 2 位13G/A6.10%股數 318.8 萬−6.50 個百分點原本 12.60%2026/5/29SEC
2026/5/2916:37 ETDeep Track Capital, LP等 3 位13G5.81%股數 305.5 萬+5.81 個百分點原本 0.00%2026/5/22SEC
2026/5/2617:10 ETPoint72 Asset Management, L.P.等 3 位13G5.20%股數 271.1 萬+1.70 個百分點原本 3.50%2026/5/22SEC
2026/5/1518:41 ETLogos Global Management LP等 5 位13G/A3.20%股數 167.5 萬−2.40 個百分點原本 5.60%低於 5%2026/3/31SEC
2026/5/1516:34 ETRa Capital Management, L.P.等 4 位13G/A9.90%股數 245.6 萬0.00 個百分點原本 9.90%2026/3/31SEC
2026/5/1516:31 ETOrbiMed Advisors LLC13G/A2.10%股數 47.5 萬−4.30 個百分點原本 6.40%低於 5%2026/3/31SEC
2026/5/1516:04 ETBiotechnology Value Fund L P等 10 位13G/A9.99%股數 234.8 萬0.00 個百分點原本 9.99%2026/3/31SEC
2026/5/1510:31 ETCaligan Partners LP等 2 位13G/A7.20%股數 163.5 萬+2.30 個百分點原本 4.90%2026/3/31SEC
2026/5/1510:06 ETT. Rowe Price Investment Management, Inc.13G9.50%股數 216.3 萬新申報2026/3/31SEC
2026/5/1508:15 ETAvoro Capital Advisors LLC等 2 位13G5.75%股數 141.0 萬新申報2026/3/31SEC
2026/5/1416:09 ETAffinity Asset Advisors, LLC等 2 位13G/A5.50%股數 134.1 萬−0.20 個百分點原本 5.70%2026/3/31SEC
2026/5/1218:09 ETTCG Crossover GP II, LLC等 3 位13G7.90%股數 301.7 萬新申報2026/5/5SEC
2026/5/611:00 ETFMR LLC等 2 位13G/A12.60%股數 287.9 萬+1.10 個百分點原本 11.50%2026/3/31SEC
2026/4/113:02 ETLogos Global Management LP等 5 位13G5.60%股數 128.5 萬新申報2026/3/26SEC
2026/3/610:05 ETFMR LLC等 2 位13G11.50%股數 212.6 萬新申報2026/2/27SEC
2026/2/2416:48 ETMillennium Management LLC等 3 位13G5.00%股數 93.4 萬+0.20 個百分點原本 4.80%2026/2/17SEC
2026/2/1718:13 ETOrbiMed Advisors LLC13G/A6.40%股數 118.7 萬−2.50 個百分點原本 8.90%2025/12/31SEC
2026/2/1717:00 ETCaligan Partners LP等 2 位13G/A4.90%股數 88.2 萬−1.40 個百分點原本 6.30%低於 5%2025/12/31SEC
2026/2/1716:33 ETPoint72 Asset Management, L.P.等 3 位13G/A3.50%股數 62.8 萬−4.50 個百分點原本 8.00%低於 5%2025/12/31SEC
2026/2/1716:21 ETRa Capital Management, L.P.等 4 位13G/A9.90%股數 193.9 萬0.00 個百分點原本 9.90%2025/12/31SEC
2026/2/1716:11 ETMillennium Management LLC等 3 位13G4.80%股數 88.7 萬−0.10 個百分點原本 4.90%低於 5%2026/2/10SEC
2026/2/1716:07 ETBiotechnology Value Fund L P等 10 位13G/A9.99%股數 190.4 萬0.00 個百分點原本 9.99%2025/12/31SEC
2026/2/1706:57 ETBalyasny Asset Management LLC等 5 位13G/A2.42%股數 43.9 萬−3.80 個百分點原本 6.22%低於 5%2025/12/31SEC
2026/2/1016:07 ETMillennium Management LLC等 3 位13G4.90%股數 90.7 萬0.00 個百分點原本 4.90%低於 5%2026/2/3SEC
2026/2/1011:36 ETSilverarc Capital Management, LLC等 2 位13G2.83%股數 52.4 萬−2.65 個百分點原本 5.48%低於 5%2025/12/31SEC
2026/2/317:19 ETMillennium Management LLC等 3 位13G4.90%股數 90.6 萬新申報低於 5%2026/1/28SEC
2026/1/3013:25 ETVanguard Group Inc13G/A4.43%股數 80.4 萬−0.83 個百分點原本 5.26%低於 5%2025/12/31SEC
2026/1/2919:56 ETAffinity Asset Advisors, LLC等 2 位13G/A5.70%股數 105.1 萬−1.95 個百分點原本 7.65%2026/1/22SEC
2025/11/1418:26 ETIkarian Capital, LLC等 2 位13G/A3.80%股數 71.2 萬−6.19 個百分點原本 9.99%低於 5%2025/9/30SEC
2025/11/1416:54 ETNantahala Capital Management, LLC等 3 位13G/A9.39%股數 123.5 萬+0.96 個百分點原本 8.43%2025/9/30SEC
2025/11/1416:12 ETRa Capital Management, L.P.等 4 位13G/A9.90%股數 138.6 萬0.00 個百分點原本 9.90%2025/9/30SEC

Form 144:內部人預計賣出

高階主管、董事與其他關係人預計賣出 Avalo Therapeutics, Inc. 股票的 16 份通知,由新到舊。

AVTX 的 Form 144
申報時間(美東)賣方預計賣出股數市值預計賣出日券商原文
2026/8/1816:18 ETChristopher Ryan Sullivan高階主管3.10 萬$62.2 萬2026/8/18Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/1716:49 ETMittie Doyle高階主管5,037$9.87 萬2026/8/1710b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/1716:47 ETChristopher Ryan Sullivan高階主管7.07 萬$138.5 萬2026/8/1710b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/1716:18 ETChristopher Ryan Sullivan高階主管3,749$7.48 萬2026/8/17Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/1116:22 ETJennifer Riley高階主管2,655$5.20 萬2026/8/11Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/1016:47 ETMittie Doyle高階主管679$1.24 萬2026/8/1010b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/6/216:08 ETJonathan Goldman董事4.28 萬$61.6 萬2026/6/2Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/716:20 ETChristopher Sullivan高階主管1.86 萬$40.6 萬2026/5/710b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/616:54 ETMittie Doyle高階主管5.45 萬$88.6 萬2026/5/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/616:32 ETChristopher Sullivan高階主管4.70 萬$76.4 萬2026/5/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/616:30 ETPaul Varki高階主管9.28 萬$150.8 萬2026/5/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/616:29 ETMitchell Chan董事3,167$5.15 萬2026/5/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/4/2916:33 ETChristopher Sullivan高階主管1.69 萬$21.8 萬2026/4/2910b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/4/616:34 ETMittie Doyle高階主管6.58 萬$116.9 萬2026/4/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/4/116:48 ETChristopher Sullivan高階主管1.60 萬$23.8 萬2026/4/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/3/1616:39 ETMittie Doyle高階主管2.95 萬$46.7 萬2026/3/1610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC